Crossmark

GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner

Crossref DOI link: https://doi.org/10.1186/s13046-019-1157-4

Published Online: 2019-04-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lin, Fen

Xie, Yu-Jie

Zhang, Xin-Ke

Huang, Tie-Jun

Xu, Hong-Fa

Mei, Yan

Liang, Hu

Hu, Hao

Lin, Si-Ting

Luo, Fei-Fei

Lang, Yan-Hong

Peng, Li-Xia

Qian, Chao-Nan

Huang, Bi-Jun
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81773162)

National Natural Science Foundation of China (81572901)

National Natural Science Foundation of China (31170151)

Natural Science Foundation of Guangdong Province (2017A030313866)

Science and Technology Planning Project of Guangdong Province (2014A020209024)

Science and Technology Planning Project of Guangdong Province (2014B020212017)
License Information

Text and Data Mining valid from 2019-04-08
More Information

Article History

Received: 4 November 2018

Accepted: 29 March 2019

First Online: 8 April 2019

Ethics approval and consent to participate

: All human tissue samples were obtained with patient consent and the approval of the Institutional Clinical Ethics Review Board at Sun Yat-Sen University Cancer Center. All animal experiments were approved by the Institutional Animal Care and Use Committee of the Sun Yat-Sen University Cancer Center.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.